Cargando…
Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study
BACKGROUND: Hepatic steatosis has a pivotal role in the development of chronic liver diseases, even in alcohol-related liver disease. Alcoholic fatty liver disease is an important phenotype among alcohol-related liver diseases. While metabolic syndrome is a dominant risk factor of incident nonalcoho...
Autores principales: | Yoshimura, Yuta, Hamaguchi, Masahide, Hashimoto, Yoshitaka, Okamura, Takuro, Nakanishi, Naoko, Obora, Akihiro, Kojima, Takao, Fukui, Michiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353849/ https://www.ncbi.nlm.nih.gov/pubmed/34372774 http://dx.doi.org/10.1186/s12876-021-01893-4 |
Ejemplares similares
-
Changes in metabolic complications in patients with alcoholic fatty liver disease monitored over two decades: NAGALA study
por: Hamaguchi, Masahide, et al.
Publicado: (2020) -
Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study
por: Okamura, Takuro, et al.
Publicado: (2021) -
Metabolic associated fatty liver disease is a risk factor for chronic kidney disease
por: Hashimoto, Yoshitaka, et al.
Publicado: (2021) -
Effect of alcohol consumption and the presence of fatty liver on the risk for incident type 2 diabetes: a population-based longitudinal study
por: Okamura, Takuro, et al.
Publicado: (2020) -
A weight regain of 1.5 kg or more and lack of exercise are associated with nonalcoholic fatty liver disease recurrence in men
por: Nakanishi, Naoko, et al.
Publicado: (2021)